In this Webcast from a CCO symposium at ASH 2018, experts discuss ADCs, BiTE, and CAR T-cell therapies in the management of adults with Ph- ALL
Read expert answers to audience questions on the use of PARP inhibitors for the treatment of breast cancer from a CCO symposium at SABCS 2018.
Downloadable slides developed by expert faculty, Mary Beth Rios, RN, CCRP and Mary Alma Welch, PAC, on newer immunotherapies for ALL
NSCLC and MPM CME activity: Anne S. Tsao, MD, offers insights on challenging cases with variable symptoms, PD-L1 expression, and driver mutations.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.